Fiduciary Trust’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$263K Sell
791
-49
-6% -$17K ﹤0.01% 765
2026
Q2
$312K Hold
840
– – ﹤0.01% 743
2026
Q1
$217K Hold
840
– – ﹤0.01% 829
2025
Q4
$207K Buy
+840
New +$177K ﹤0.01% 834

Other funds holding KRYS

Fiduciary Trust's KRYS Position: Q3 2026 in Review

Fiduciary Trust reduced its Krystal Biotech (KRYS) stake by 5.8% in Q3 2026, selling an estimated $17K and leaving 791 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #765.

Fiduciary Trust first reported a position in KRYS in Q4 2025 and has held it in 4 quarters since. The position peaked at $312K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Fiduciary Trust held 791 shares of Krystal Biotech worth $263K as of Q3 2026.
  • Fiduciary Trust sold 49 Krystal Biotech shares in Q3 2026, an estimated $17K.
  • Krystal Biotech made up ﹤0.01% of Fiduciary Trust's portfolio in Q3 2026, its #765 holding.
  • Fiduciary Trust first reported a position in Krystal Biotech in Q4 2025 and has held it in 4 quarters since.
  • Fiduciary Trust's Krystal Biotech position peaked at $312K in Q2 2026.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Fiduciary Trust's 13F filing for Q3 2026, filed 16 Nov 2026.